Macquarie Home | Course Handbook | Library | Campus Map | Macquarie Contacts
Home page

Macquarie University ResearchOnline

Home
Add
-List Of Titles -Forecasting risk in acute myocardial infarction

Please use this identifier to cite or link to this item: http://hdl.handle.net/1959.14/165009

124 Visitors 214 Hits 44 Downloads
FileDescriptionSizeFormat
SOURCE201front.pdf175 KBAdobe Acrobat PDFView/Open
SOURCE302whole.pdf1 MBAdobe Acrobat PDFView/Open
Title
Forecasting risk in acute myocardial infarction
Related
Australasian Digital Theses
Publisher
Australia : Macquarie University
Date
2011
Author/Creator
O'Connell, Rachel Leigh
Description
"Research conducted in association with: NHMRC Clinical Trials Centre, University of Sydney".
Description
Thesis (PhD)--Macquarie University, Faculty of Science, Dept. of Statistics, 2011.
Description
Bibliography: p. 133-137.
Description
Introduction -- Methods -- Risk models for acute myocardial infarction based on a geographically diverse trial population -- International differences in clinical outcomes after acute myocardial infarction -- Risk of mortality after acute myocardial infarction: performance of model updating methods for application in different geographical regions -- Cross-trial comparisons of risk models -- Discussion.
Description
Coronary heart disease is the most common cause of death worldwide with an estimated 7 million deaths per year. The majority of these deaths are due to acute myocardial infarction (AMI) so the burden of illness and mortality from AMI worldwide is immense. Existing short-term risk assessment strategies in AMI are limited to Western patient populations. In this thesis we have proposed risk models for prediction of mortality after AMI based on the geographically diverse Hirulog and Early Reperfusion or Occlusion (HERO-2) trial. The HERO-2 trial randomised 17 073 patients to either unfractionated heparin or bivalirudin in conjunction with fibrinolytic therapy with streptokinase, for the treatment of ST-segment Elevation MI. Patients were recruited from 46 countries from Europe, North and Latin America and Asia, including Australia, New Zealand and Russia. We have developed a comprehensive risk model to identify significant predictors of 30-day mortality. This model was subsequently simplified to a basic risk index and predictive accuracy was compared. We have also proposed two new methods for directly comparing the calibration and ranking performance of two risk strategies. -- The geographical diversity of the HERO-2 trial also provided a unique opportunity to examine international differences in clinical outcomes following AMI. We have undertaken a comprehensive comparison of patient characteristics, treatment and outcomes across 5 pre-specified regions: Western countries, Latin America, Eastern Europe, Russia and Asia. We found that mortality rates were lower in Western countries and that these differences could not be attributed to patient case-mix, treatments or national health and economic statistics. -- An important issue in applying findings from randomised clinical trials is the procedure to estimate risk among members of other patient populations. Using the HERO-2 trial we compared methods for updating risk models for AMI. A variety of re-calibration and model revision strategies were compared with a global modeling strategy having a built-in region effect. The relative performance of these methods in the different geographical regions, which vary in sample size, was of primary interest. Model revision was found to only provide a slight improvement in predictive performance over the global model. We concluded that a global model with regional re-calibration is adequate. We also studied data from 5 additional multinational trials: GUSTO-1, GUSTO-2b, GUSTO-3, ASSENT-2 and ASSENT-3. We further explored the adequacy of applying simple re-calibration to update a model for the context of applying a previously developed model to a new trial. We found that new models do not need to be developed for risk assessment in new trials; prior models with recalibration will suffice.
Description
Mode of access: World Wide Web.
Description
ix, 147 p. ill. (some col.)
Subject Keyword
Myocardial infarction -- Risk factors -- Mathematical models
Subject Keyword
Myocardial infarction -- Risk factors -- Statistical methods
Subject Keyword
Myocardial infarction -- Mortality
Subject Keyword
acute myocardial infarction
Subject Keyword
risk assessment
Subject Keyword
prediction
Subject Keyword
mortality
Subject Keyword
prognostic index
Subject Keyword
calibration
Subject Keyword
risk factors
Resource Type
Thesis PhD
Organisation
Macquarie University. Dept. of Statistics

Identifier
http://hdl.handle.net/1959.14/165009
Identifier
1609389
Language
eng
Rights
Copyright disclaimer: http://www.copyright.mq.edu.au
Rights
Copyright Rachel Leigh O'Connell 2011.
Full Text
Full Text
 
Image Thumbnail
Save/E-mail Citation
Citation Format
E-mail Address
Subject
"Forecasting risk in acute myocardial infarction"
 
OR
  • Show All  
  • Show My Selections 
Advanced Search

Search

Browse

  • By Title 
  • By Author/Creator 
  • By Department/Centre 
  • By Subject Keyword 
  • By Journal/Conference 
  • By FoR/RFCD codes 
  • By Resource Type 
  • By Date 

Highlights

  • Most Accessed Objects 
  • Recent Additions 
  • Pending Publications 
  • Author Profiles 

Resources

  • About ResearchOnline 
  • FAQ 
  • Open Access 
  • Open Access-FAQs 
  • Copyright 
  • Contribute 
  • Help 
  • Contact
  • Terms and Conditions 
Valid XHTML 1.0 Strict Powered by VITAL

Copyright Macquarie University | Privacy Statement | Accessibility Information

ABN 90 952 801 237 | CRICOS Provider No 00002J

Library Staff Sign In